Propyl 2-methylisocrotonate
Common Name: |
Propyl 2-methylisocrotonate |
IUPAC Name: |
propyl (Z)-2-methylbut-2-enoate |
Molecular Formula: |
C8H14O2 |
SMILES: |
CCCOC(=O)C(=CC)C |
Inchi: |
1S/C8H14O2/c1-4-6-10-8(9)7(3)5-2/h5H,4,6H2,1-3H3/b7-5- |
Inchi Key: |
RZWMDOQSXWAAMC-ALCCZGGFSA-N |
Cas No: |
53082-57-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
142.20 |
Mass (g/mol) |
142.099 |
Molar Refractivity |
41.38 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
4 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
171.00 to 172.00 |
Vapor Pressure (mmHg@25.00 °C) |
1.39 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.62 |
LogP |
1.906 |
iLOGP |
2.58 |
XLOGP3 |
2.21 |
WLOGP |
1.91 |
MLOGP |
1.85 |
ESOL Log S |
-1.85 |
ESOL Solubility (mg/ml) |
2.01 |
ESOL Solubility (mol/l) |
0.014 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.40 |
Ali Solubility (mg/ml) |
0.57 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.60 |
Silicos-IT Solubility (mg/ml) |
3.53 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.60 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.824 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.469 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |